[pending] Peloton Recalls Original Series Bike+ Exercise Bikes Due to Fall and Injury Hazards
Pending LLM rewrite. Source: CPSC 26067.
- Product
- Peloton Original Series Bike+ Model PL02
- Category
- Consumer Product
- Distribution
- Distributed nationwide
State
19,789 recalls have nationwide distribution and so reach New Jersey. 0 additional recalls listed New Jersey specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect New Jersey consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: CPSC 26067.
Pending LLM rewrite. Source: CPSC 26073.
Pending LLM rewrite. Source: CPSC 26081.
Pending LLM rewrite. Source: NHTSA 25V387000.
Pending LLM rewrite. Source: CPSC 26072.
Pending LLM rewrite. Source: CPSC 26074.
Pending LLM rewrite. Source: CPSC 26071.
Pending LLM rewrite. Source: CPSC 26069.
Pending LLM rewrite. Source: FDA_DEVICE Z-0403-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0394-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0113-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0339-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0362-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0412-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0309-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0398-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0146-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0401-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0371-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0143-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0390-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0399-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0140-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0382-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0328-2026.